Advertisement
Advertisement
MDWD
MediWound Ltd.
16.84
USDSponsored
-0.05
-0.30%
May 21, 16:00 UTC -4
Closed
After-Market
16.84
0.00
0.00%
MDWD Earnings Reports
Positive Surprise Ratio
MDWD beat 22 of 40 last estimates.
55%
Next Report
Next Week
Date of Next Report
May 27, 2026
Estimate for Q1 26 (Revenue/ EPS)
$3.18M
/-$0.66
Implied change from Q4 25 (Revenue/ EPS)
+70.31%
/+17.86%
Implied change from Q1 25 (Revenue/ EPS)
-19.60%
/+842.86%
MediWound Ltd. earnings per share and revenue
On Mar 05, 2026, MDWD reported earnings of -0.56 USD per share (EPS) for Q4 25, beating the estimate of -0.64 USD, resulting in a 13.08% surprise. Revenue reached 1.87 million, compared to an expected 6.23 million, with a -70.05% difference. The market reacted with a -0.85% price change (close before vs. close after earnings).
Looking ahead to Q1 26, 6 analysts forecast an EPS of -0.66 USD, with revenue projected to reach 3.18 million USD, implying an increase of 17.86% EPS, and increase of 70.31% in Revenue from the last quarter.
Industry Peers’ Earnings
Industry Peers' Earnings displays EPS earnings data from companies in the same industry. Click on a card to view more details.
ARS Pharmaceuticals, Inc. Common Stock
Report Date
May 15, 2026 For Q1 26
Estimate
-$0.53
Actual
-$0.61
Surprise
-13.81%
ProKidney Corp. Class A Ordinary Shares
Report Date
May 15, 2026 For Q1 26
Estimate
-$0.14
Actual
-$0.14
Surprise
+0.57%
Galectin Therapeutics Inc.
Report Date
May 15, 2026 For Q1 26
Estimate
-$0.06
Actual
-$0.08
Surprise
-30.72%
NRX Pharmaceuticals, Inc. Common Stock
Report Date
May 15, 2026 For Q1 26
Estimate
$0.29
Actual
-$0.04
Surprise
-113.64%
Incannex Healthcare Limited - ADR
Report Date
May 15, 2026 For Q3 26
Estimate
-$0.94
Actual
-$11.22
Surprise
-1088.38%
VYNE Therapeutics Inc. Common Stock
Report Date
May 15, 2026 For Q1 26
Estimate
-$0.18
Actual
-$0.08
Surprise
+56.43%
Wellgistics Health, Inc. Common Stock
Report Date
May 19, 2026 For Q1 26
Estimate
-Actual
-$0.07
Surprise
-
Traws Pharma, Inc. Common Stock
Report Date
May 15, 2026 For Q1 26
Estimate
-$0.75
Actual
-$0.53
Surprise
+29.78%
60 Degrees Pharmaceuticals, Inc. Common Stock
Report Date
May 15, 2026 For Q1 26
Estimate
-$0.77
Actual
-$1.28
Surprise
-65.12%
AIM ImmunoTech Inc.
Report Date
May 15, 2026 For Q1 26
Estimate
-$0.37
Actual
-$0.56
Surprise
-52.53%
FAQ
What were MediWound Ltd.'s earnings and revenue for the latest quarter Q4 2025?
For Q4 2025, MediWound Ltd. reported EPS of -$0.56, beating estimates by 13.08%, and revenue of $1.87M, -70.05% below expectations.
How did the market react to MediWound Ltd.'s Q4 2025 earnings?
The stock price moved down -0.85%, changed from $17.60 before the earnings release to $17.45 the day after.
When is MediWound Ltd. expected to report next?
The next earning report is scheduled for May 27, 2026.
What are the forecasts for MediWound Ltd.'s next earnings report?
Based on 6
analysts, MediWound Ltd. is expected to report EPS of -$0.66 and revenue of $3.18M for Q1 2026.
Which companies are reporting earnings today?
Check FXEmpire's Earnings Calendar for today's list of reporting companies.
Advertisement